These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 32021108

  • 1. Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.
    Li S, Zhang J, Fang Y, Yi J, Lu Z, Chen Y, Guo B.
    Drug Des Devel Ther; 2020; 14():243-256. PubMed ID: 32021108
    [Abstract] [Full Text] [Related]

  • 2. [Preparation and characterization of icariin nanosuspension and lyophilized powder].
    Hui-Rong XI, Hui-Ping MA, Ke-Ming C, Xiao-Shuan L.
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4902-4908. PubMed ID: 33350263
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
    Wang R, Yang M, Li G, Wang X, Zhang Z, Qiao H, Chen J, Chen Z, Cui X, Li J.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():270-279. PubMed ID: 30469048
    [Abstract] [Full Text] [Related]

  • 4. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.
    Wang Y, Liu Z, Zhang D, Gao X, Zhang X, Duan C, Jia L, Feng F, Huang Y, Shen Y, Zhang Q.
    Colloids Surf B Biointerfaces; 2011 Apr 01; 83(2):189-97. PubMed ID: 21176876
    [Abstract] [Full Text] [Related]

  • 5. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 6. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN.
    Int J Pharm; 2017 Oct 05; 531(1):153-166. PubMed ID: 28823888
    [Abstract] [Full Text] [Related]

  • 7. Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 32 Factorial Design to Improve Solubility and In Vitro Bioavailability.
    Alhamhoom Y, Honmane SM, Hani U, Osmani RAM, Kandasamy G, Vasudevan R, Paramshetti S, R Dudhal R, K Kengar N, Charde MS.
    Polymers (Basel); 2023 Jan 17; 15(3):. PubMed ID: 36771784
    [Abstract] [Full Text] [Related]

  • 8. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA, ElMeshad AN, Fares AR.
    AAPS PharmSciTech; 2017 May 17; 18(4):983-996. PubMed ID: 27506564
    [Abstract] [Full Text] [Related]

  • 9. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K, Narendar D, Kishan V.
    Drug Dev Ind Pharm; 2017 Jul 17; 43(7):1186-1196. PubMed ID: 28271908
    [Abstract] [Full Text] [Related]

  • 10. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
    Tan JM, Karthivashan G, Arulselvan P, Fakurazi S, Hussein MZ.
    Drug Des Devel Ther; 2014 Jul 17; 8():2333-43. PubMed ID: 25429205
    [Abstract] [Full Text] [Related]

  • 11. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
    Qiao F, Zhao Y, Mai Y, Guo J, Dong L, Zhang W, Yang J.
    Planta Med; 2020 May 17; 86(8):538-547. PubMed ID: 32294789
    [Abstract] [Full Text] [Related]

  • 12. The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity.
    Mohyeldin SM, Mehanna MM, Elgindy NA.
    Int J Nanomedicine; 2016 May 17; 11():2209-22. PubMed ID: 27274244
    [Abstract] [Full Text] [Related]

  • 13. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
    Li X, Yuan H, Zhang C, Chen W, Cheng W, Chen X, Ye X.
    J Pharm Pharmacol; 2016 Aug 17; 68(8):980-8. PubMed ID: 27283220
    [Abstract] [Full Text] [Related]

  • 14. Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.
    Zhang T, Li X, Xu J, Shao J, Ding M, Shi S.
    Pharmaceutics; 2022 Apr 24; 14(5):. PubMed ID: 35631508
    [Abstract] [Full Text] [Related]

  • 15. [Preparation of herpetolide A nanosuspension lyophilized powder and evaluation of its anti-hepatitis B virus activity].
    Zhong YJ, Liu QC, Zhang T, Liu X, Wang LQ, Yuan HL.
    Zhongguo Zhong Yao Za Zhi; 2020 Mar 24; 45(5):1076-1081. PubMed ID: 32237449
    [Abstract] [Full Text] [Related]

  • 16. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.
    Shelar DB, Pawar SK, Vavia PR.
    Drug Deliv Transl Res; 2013 Oct 24; 3(5):384-91. PubMed ID: 25788346
    [Abstract] [Full Text] [Related]

  • 17. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects.
    Zhong Y, Hang L, Wang F, Shen B, Shen C, Xue Y, Jia H, Wang L, Yuan H.
    J Microencapsul; 2023 Dec 24; 40(8):587-598. PubMed ID: 37733492
    [Abstract] [Full Text] [Related]

  • 18. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS, Elnaggar YS, Abdallah OY.
    Int J Pharm; 2013 Sep 15; 454(1):462-71. PubMed ID: 23830765
    [Abstract] [Full Text] [Related]

  • 19. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z.
    Int J Pharm; 2009 Sep 08; 379(1):167-73. PubMed ID: 19505545
    [Abstract] [Full Text] [Related]

  • 20. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
    Li Y, Wang Y, Gao L, Tan Y, Cai J, Ye Z, Chen AT, Xu Y, Zhao L, Tong S, Sun Q, Liu B, Zhang S, Tian D, Deng G, Zhou J, Chen Q.
    J Nanobiotechnology; 2022 Jan 21; 20(1):39. PubMed ID: 35062946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.